Skip NavigationSkip to Content
Return Return to Search Results

Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion

  1. Author:
    Santhanam, A. N.
    Baker, A. R.
    Hegamyer, G.
    Kirschmann, D. A.
    Colburn, N. H.

  2. Author Address

    [Santhanam, A. N.; Baker, A. R.; Hegamyer, G.; Colburn, N. H.] NCI, Gene Regulat Sect, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21702 USA. [Kirschmann, D. A.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Childrens Mem Res Ctr,Canc Biol & Epigen Program, Chicago, IL 60611 USA.;Santhanam, AN, NCI, Gene Regulat Sect, Lab Canc Prevent, Ctr Canc Res, Boyles St, Frederick, MD 21702 USA.;santhanama@ncifcrf.gov
    1. Year: 2010
    2. Date: Jul
  2. Journal: Oncogene
    1. 29
    2. 27
    3. Pages: 3921-3932
  4. Type of Article: Article
  5. ISSN: 0950-9232
  1. Abstract:

    Metastasis to bone, liver and lungs is the primary cause of death in breast cancer patients. Our studies have revealed that the novel tumor suppressor Pdcd4 inhibits breast cancer cell migration and invasion in vitro. Loss of Pdcd4 in human nonmetastatic breast cancer cells increased the expression of lysyl oxidase (LOX) mRNA. LOX is a hypoxia-inducible amine oxidase, the activity of which enhances breast cancer cell invasion in vitro and in vivo. Specific inhibition of LOX activity by beta-aminopropionitrile or small interfering RNA decreased the invasiveness of T47D and MCF7 breast cancer cells attenuated for Pdcd4 function. Most significantly, loss of Pdcd4 augments hypoxia induction of LOX as well. Conversely, overexpression of Pdcd4 significantly reversed the hypoxia induction of LOX expression in T47D cells attenuated for Pdcd4. However, Pdcd4 did not affect hypoxia-inducible factor-1 (HIF-1) protein expression or HIF-1-responsive element-luciferase activity in response to hypoxia, suggesting that Pdcd4 regulation of LOX occurs through an HIF-independent mechanism. Nevertheless, the loss of Pdcd4 early in cancer progression may have an important role in the increased sensitivity of cancer cells to hypoxia through increased LOX activity and concomitant enhanced invasiveness. Oncogene (2010) 29, 3921-3932; doi:10.1038/onc.2010.158; published online 24 May 2010

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1038/onc.2010.158
  3. View record in Web of Science®
  4. WOS: 000279603200005

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel